S-Adenosyl-L-methionine (1,4-butanedisulfonate)

CAT:
804-HY-B0617B
Size:
Inquire

For Laboratory Research Only. Not for Clinical or Personal Use.

  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
S-Adenosyl-L-methionine (1,4-butanedisulfonate) - image 1

S-Adenosyl-L-methionine (1,4-butanedisulfonate)

  • UNSPSC Description:

    S-Adenosyl-L-methionine (S-Adenosyl methionine) 1,4-butanedisulfonate is an orally active methyl group donor. S-Adenosyl-L-methionine 1,4-butanedisulfonate is a dietary supplement with potent antidepressant effects. S-Adenosyl-L-methionine 1,4-butanedisulfonate also has anti‑proliferative, pro‑apoptotic and anti‑metastatic roles in cancers. S-Adenosyl-L-methionine 1,4-butanedisulfonate has the potential for, cancer, liver disease and osteoarthritis research[1][2][3].
  • Target Antigen:

    Apoptosis; Endogenous Metabolite
  • Type:

    Reference compound
  • Related Pathways:

    Apoptosis;Metabolic Enzyme/Protease
  • Applications:

    COVID-19-immunoregulation
  • Field of Research:

    Cancer; Inflammation/Immunology; Neurological Disease
  • Assay Protocol:

    https://www.medchemexpress.com/s-adenosyl-l-methionine-1-4-butanedisulfonate.html
  • Solubility:

    10 mM in DMSO
  • Smiles:

    O=S(CCCCS(=O)(O)=O)(O)=O.O[C@H]1[C@@H](O[C@@H]([C@H]1O)C[S+](C)CC[C@H](N)C([O-])=O)N2C3=NC=NC(N)=C3N=C2
  • Molecular Weight:

    616.69
  • References & Citations:

    [1]G M Bressa. S-adenosyl-l-methionine (SAMe) as antidepressant: meta-analysis of clinical studies. Acta Neurol Scand Suppl. 1994;154:7-14.|[2]Wadie I Najm, et al. S-adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: a double-blind cross-over trial. [ISRCTN36233495]. BMC Musculoskelet Disord. 2004 Feb 26;5:6. |[3]Shelly C Lu, et al. S-adenosylmethionine in liver health, injury, and cancer. Physiol Rev. 2012 Oct;92(4):1515-42. |[4]Mosca L, et al. Effects of S‑adenosyl‑L‑methionine on the invasion and migration of head and neck squamous cancer cells and analysis of the underlying mechanisms. Int J Oncol. 2020 May;56(5):1212-1224. |[5]Ham MS, et al. S-adenosyl methionine specifically protects the anticancer effect of 5-FU via DNMTs expression in human A549 lung cancer cells. Mol Clin Oncol. 2013 Mar;1(2):373-378. |[6]Ornoy A, et al. S-adenosyl methionine prevents ASD like behaviors triggered by early postnatal valproic acid exposure in very young mice. Neurotoxicol Teratol. 2019 Jan-Feb;71:64-74.|[7]Dhediya RM, et al. Evaluation of antiepileptic effect of S-adenosyl methionine and its role in memory impairment in pentylenetetrazole-induced kindling model in rats. Epilepsy Behav. 2016 Aug;61:153-157. J Pharm Biomed Anal. 2024 Jan 20, 115991.|Biochem Pharmacol. 2023 Dec 6:219:115967.|bioRxiv. 2023 Jun 1.|Epigenetics Chromatin. 2021 Dec 4;14(1):52.|Int Immunopharmacol. 2021 Mar 22;95:107545.|J Agric Food Chem. 2021 Jul 30.|Research Square Preprint. 2020 Aug.|Research Square Preprint. 2021 Jun.|J Cell Physiol. 2024 Oct 6:e31452.|Molecules. 2023 Apr 11, 28(8), 3375.|Pharmacol Res. 2024 Sep 16:107420.
  • Shipping Conditions:

    Room temperature
  • Clinical Information:

    Phase 4
  • CAS Number:

    200393-05-1